Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
18%
Ph not_applicable
9
82%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (18.2%)
N/A9 (81.8%)

Trials by Status

completed764%
recruiting327%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11